Structure of the Fc fragment of human IgE bound to its high-affinity receptor FcεRIα

Nature

Volumn 406, Issue 6793, 2000, Pages 259-266

  Garman, Scott C ^a   Wurzburg, Beth A ^a   Tarchevskaya, Svetlana S ^a   Klnet, Jean Pierre ^b   Jardetzky, Theodore S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN FC FRAGMENT;

ALLERGY; ANIMAL CELL; ARTICLE; ASTHMA; CRYSTAL STRUCTURE; IMMUNOGLOBULIN STRUCTURE; MOLECULAR INTERACTION; MUTATION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING;

ANTIBODY SPECIFICITY; CRYSTALLOGRAPHY, X-RAY; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN FRAGMENTS; MACROMOLECULAR SUBSTANCES; MODELS, MOLECULAR; MUTATION; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, IGE; RECOMBINANT PROTEINS;

ANIMALIA;

EID: 0034691520     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35018500     Document Type: Article

References (50)

1. Metzger, H. The receptor with high affinity for IgE. Immunol. Rev. 125, 37-48 (1992).
2. Kinet, J. P. The high-affinity IgE receptor (Fc∈RI): from physiology to pathology. Annu. Rev. Immunol. 17, 931-972 (1999).
3. Basu, M. et al. Purification and characterization of human recombinant IgE-Fc fragments that bind to the human high affinity IgE receptor. J. Biol. Chem. 268, 13118-13127 (1993).
4. Keown, M. B. et al. Hydrodynamic studies of a complex between the Fc fragment of human IgE and a soluble fragment of the Fc∈RI α-chain. Proc. Natl. Acad. Sci. USA 92, 1841-1845 (1995).
5. Keown, M. B., Ghirlando, R., Mackay, G. A., Sutton, B. J. & Gould, H. J. Basis of the 1:1 stoichiometry of the high affinity receptor Fc∈RI-IgE complex. Eur. Biophys. J. 25, 471-476 (1997).
6. Daeron, M. Fc receptor biology. Annu. Rev. Immunol. 15, 203-234 (1997).
7. Turner, H. & Kinet, J. P. Signalling through the high-affinity IgE receptor Fc∈RI. Nature 402 (Suppl. B), 24-30 (1999).
8. Ravetch, J. V. & Clynes, R. A. Divergent roles for Fc receptors and complement in vivo. Annu. Rev. Immunol. 16, 421-432 (1998).
9. Cookson, W. The alliance of genes and environment in asthma and allergy. Nature 402 (suppl. B), 5-11 (1999).
10. Jardieu, P. M. & Fick, R. B. Jr IgE inhibition as a therapy for allergic disease. Int. Arch. Allergy Immunol. 118, 112-115 (1999).
11. Chang, T. W. The pharmacological basis of anti-IgE therapy. Nature Biotechnol. 18, 157-162 (2000).
12. Garman, S. C., Kinet, J. P. & Jardetzky, T. S. Crystal structure of the human high-affinity IgE receptor. Cell 95, 951-961 (1998).
13. Nissim, A., Jouvin, M. H. & Eshhar, Z. Mapping of the high affinity Fc∈-receptor binding site to the third constant region domain of IgE. EMBO J. 10, 101-107 (1991).
14. Keegan, A. D., Fratazzi, C., Shopes, B., Baird, B. & Conrad, D. H. Characterization of new rat anti-mouse IgE monoclonals and their use along with chimeric IgE to further define the site that interacts with Fc∈RII and Fc∈RI. Mol. Immunol. 28, 1149-1154 (1991).
15. Presta, L. et al. The binding site on human immunoglobulin E for its high affinity receptor. J. Biol. Chem. 269, 26368-26373 (1994).
16. Henry, A. J. et al. Participation of the N-terminal region of C∈3 in the binding of human IgE to its high-affinity receptor Fc∈RI. Biochemistry 36, 15568-15578 (1997).
17. Granato, D. A. & Neeser, J. R. Effect of trimming inhibitors on the secretion and biological activity of a murine IgE monoclonal antibody. Mol. Immunol. 24, 849-855 (1987).
18. Letourneur, O., Sechi, S., Willette-Brown, J., Robertson, M. W. & Kinet. J. P. Glycosylation of human truncated Fc∈RI α-chain is necessary for efficient folding in the endoplasmic reticulum. J. Biol. Chem. 270, 8249-8256 (1995).
19. Kanellopoulos, J. M., Liu, T. Y., Poy, G. & Melzger, H. Composition and subunit structure of the cell receptor for immunoglobulin E. J. Biol. Chem. 255, 9060-9066 (1980).
20. Robertson, M. W. Phage and Escherichia coli expression of the human high affinity immunoglobulin E receptor α-subunit ectodomain. Domain localization of the IgE-binding site. J. Biol. Chem. 268, 12736-12743 (1993).
21. Maxwell, K. F. et al. Crystal structure of the human leukocyte Fc receptor, FcγRIIa. Nature Struct. Biol. 6, 437-442 (1999).
22. Sondermann, P., Huber, R. & Jacob, U. Crystal structure of the soluble form of the human FcγRIIb: a new member of the immunoglobulin superfamily at 1.7 Å resolution. EMBO J. 18, 1095-1103 (1999).
23. Sondermann, P., Jacob, U., Kutscher, C. & Frey, J. Characterization and crystallization of soluble human FcγRII (CD32) isoforms produced in insect cells. Biochemistry 38, 8469-8477 (1999).
24. Sanchez, L. M., Penny, D. M. & Bjorkman, P. J. Stoichiometry of the interaction between the major histocompatibility complex-related Fc receptor and its Fc ligand. Biochemistry 38, 9471-9476 (1999).
25. Shi, J. et al. Interaction of the low-affinity receptor CD23/Fc∈RII lectin domain with the Fc∈3-4 fragment of human immunoglobulin E. Biochemistry 36, 2112-2122 (1997).
26. Deisenhofer, J., Colman, P. M., Epp, O. & Huber, R. Crystallographic structural studies of a human Fc fragment. II. A complete model based on a Fourier map at 3.5 Å resolution. Hoppe Seylers Z. Physiol. Chem. 357, 1421-1434 (1976).
27. Harris, L. J., Larson, S. B. & McPherson, A. Comparison of intact antibody structures and the implications for effector function. Adv. Immunol. 72, 191-208 (1999).
28. Schreiber, S. L. Target-oriented and diversity-oriented organic synthesis in drug discovery. Science 287, 1964-1969 (2000).
29. Mallamaci, M. A. et al. Identification of sites on the human Fc∈RI α-subunit which are involved in binding human and rat IgE. J. Biol. Chem. 268, 22076-22083 (1993).
30. Hulett, M. D. Witort, E., Brinkworth, R. I., McKenzie, I. F. & Hogarth, P. M. Identification of the IgG binding site of the human low affinity receptor for IgG FcγRII. Enhancement and ablation of binding by site-directed mutagenesis. J. Biol. Chem. 269, 15287-15293 (1994).
31. Hulett, M. D., Witort, E., Brinkworth, R. I., McKenzie, I. F. & Hogarth, P. M. Multiple regions of human FcγRII (CD32) contribute to the binding of IgG. J. Biol. Chem. 270, 21188-21194 (1995).
32. Cook, J. P. et al. Identification of contact residues in the IgE binding site of human Fc∈RIα. Biochemistry 36, 15579-15588 (1997).
33. Hulett, M. D., Brinkworth, R. I., McKenzie, I. F. & Hogarth, P. M. Fine structure analysis of interaction of Fc∈RI with IgE. J. Biol. Chem. 274, 13345-13352 (1999).
34. Sayers, I. et al. Amino acid residues that influence Fc∈RI-mediated effector functions of human immunoglobulin E. Biochemistry 37, 16152-16164 (1998).
35. Anderson, C. L., Ryan, D. H., Looney, R. J. & Leary, P. C. Structural polymorphism of the human monocyte 40 kilodalton Fc receptor for IgG. J. Immunol. 138, 2254-2256 (1987).
36. Duncan, A. R., Woof, J. M., Partridge, L. J., Burton, D. R. & Winter, G. Localization of the binding site for the human high-affinity Fc receptor on IgG. Nature 332, 563-564 (1988).
37. Chappel, M. S. et al. Identificalion of the Fcγ-receptor class I binding site in human IgG through the use of recombinant IgG1/IgG2 hybrid and point-mutated antibodies. Proc. Natl Acad. Sci. USA 88, 9036-9040 (1991).
38. Hulett, M. D., McKenzie, I. F. & Hogarth, P. M. Chimeric Fc receptors identify immunoglobulin-binding regions in human FcγRII and Fc∈RI. Eur. J. Immunol. 23, 640-645 (1993).
39. Jefferis, R., Lund, I. & Pound, J. D. IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation. Immunol. Rev. 163, 59-76 (1998).
40. Keown, M. B., Henry, A. J., Ghirlando, R., Sutton, B. J. & Gould, H. J. Thermodynamics of the interaction of human immunoglobulin E with its high-affinity receptor Fc∈RI. Biochemistry 37, 8863-8869 (1998).
41. Zheng, Y., Shopes, B., Holowka, D. & Baird, B. Dynamic conformations compared for IgE and IgG1 in solution and bound to receptors. Biochemistry 31, 7446-7456 (1992).
42. Dorrington, K. J. & Bennich, H. H. Structure-function relationships in human immunoglobulin E. Immunol. Rev. 41, 3-25 (1978).
43. Otwinowski, Z. & Minor, W. in Methods in Enzymology: Macromolecular Crystallography, Part A (eds Carter, C. W. Jr & Sweet, R. M.) 307-326 (Academic, New York, 1997).
44. Collaborative Computational Project No. 4. The CCP4 Suite: Programs for Protein Crystallography. Acta Crystallogr. D 50, 760-763 (1994).
45. Kissinger, C. R., Gehlhaar, D. K. & Fogel, D. B. Rapid automated molecular replacement by evolutionary search. Acta Crystallogr. D 55, 484-491 (1999).
46. Harris, L. J., Larson, S. B., Hasel, K. W. & McPherson, A. Refined structure of an intact IgG2a monoclonal antibody. Biochemistry 36, 1381-1597 (1997).
47. Jones, T. A., Zou, I. Y., Cowan, S. W. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110-119 (1991).
48. Brenger, A. T. et al. Crystallography & NMK system: A new software suite for macromolecular structure determination. Acta Crystallogr. D 54, 905-921 (1998).
49. Kraulis, P. J. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946-950 (1991).
50. Nicholls, A., Sharp, K. A. & Honig, B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins Struct. Fund. Genet. 11, 281-296 (1991).